We are live on ! Find out more
AC

Aaron Cowen Suvretta Capital Management

AUM $5.47B
1-Year Est. Return 131.34%
 

Aaron Cowen is the founder of Suvretta Capital Management, a long/short equity firm with a fundamental research process. The firm invests across sectors with an emphasis on differentiated fundamental views. Cowen’s disclosures are tracked by investors who follow mid-to-large fundamental hedge funds.

This Fund
S&P 500
This Quarter Est. Return
+6.3%
1 Year Est. Return
+131.34%
3 Year Est. Return
+363.85%
5 Year Est. Return
+515.73%
10 Year Est. Return
+2,786.05%
AUM
$2.37B
AUM Growth
-$13.6M
Cap. Flow
+$14.5M
Cap. Flow %
0.61%
Top 10 Hldgs %
39.42%
Holding
115
New
26
Increased
36
Reduced
14
Closed
20

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$60.1M
2
AMZN icon
Amazon
AMZN
+$54.1M
3
YUM icon
Yum! Brands
YUM
+$51M
4
RPRX icon
Royalty Pharma
RPRX
+$39.8M
5
ETNB
89bio
ETNB
+$28.8M

Top Sells

Rank Stock Value
1
OTIS icon
Otis Worldwide
OTIS
+$102M
2
TPR icon
Tapestry
TPR
+$83M
3
LVS icon
Las Vegas Sands
LVS
+$78.1M
4
UNP icon
Union Pacific
UNP
+$56.7M
5
T icon
AT&T
T
+$54.3M

Sector Composition

Rank Sector Weight
1 Healthcare 48.7%
2 Consumer Discretionary 12.85%
3 Technology 6.69%
4 Communication Services 5.61%
5 Consumer Staples 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
1
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.2B
$139M 5.86%
+1,820,000
New +$151M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$809B
$127M 5.36%
+310,000
New +$124M
RPRX icon
3
Royalty Pharma
RPRX
$27.3B
$110M 4.64%
3,047,049
+1,072,424
+54% +$39.8M
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$106M 4.49%
973,755
+99,464
+11% +$11M
KURA icon
5
Kura Oncology
KURA
$1.06B
$80.4M 3.4%
6,573,335
+196,520
+3% +$2.45M
UNH icon
6
UnitedHealth
UNH
$350B
$78.1M 3.3%
165,164
-91,550
-36% -$44.2M
META icon
7
Meta Platforms (Facebook)
META
$1.4T
$75.1M 3.17%
354,198
+107,939
+44% +$18.4M
ACLX
8
DELISTED
Arcellx
ACLX
$73.9M 3.12%
2,398,321
+47,988
+2% +$1.46M
WYNN icon
9
Wynn Resorts
WYNN
$10.3B
$72.7M 3.07%
649,761
-35,240
-5% -$3.69M
ELV icon
10
Elevance Health
ELV
$86.9B
$71.4M 3.02%
155,321
+126,350
+436% +$60.1M
ITCI
11
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$64.9M 2.74%
1,198,971
+162,023
+16% +$7.83M
AMD icon
12
Advanced Micro Devices
AMD
$773B
$61.1M 2.58%
622,916
+139,160
+29% +$11.3M
HLT icon
13
Hilton Worldwide
HLT
$73.5B
$59.5M 2.51%
422,094
-14,662
-3% -$2.06M
AMZN icon
14
Amazon
AMZN
$2.79T
$57.8M 2.44%
+559,490
New +$54.1M
EL icon
15
Estee Lauder
EL
$36.9B
$56.4M 2.38%
228,806
-169,700
-43% -$43.1M
CEG icon
16
Constellation Energy
CEG
$96.7B
$55.2M 2.33%
702,609
+270,640
+63% +$21.9M
CL icon
17
Colgate-Palmolive
CL
$72.6B
$54.4M 2.3%
724,140
+79,560
+12% +$5.92M
BHVN icon
18
Biohaven
BHVN
$2.09B
$52.6M 2.22%
3,848,938
– –
YUM icon
19
Yum! Brands
YUM
$41.8B
$52.3M 2.21%
+396,050
New +$51M
INSM icon
20
Insmed
INSM
$27.5B
$50M 2.11%
2,932,138
+411,237
+16% +$7.99M
UNP icon
21
Union Pacific
UNP
$183B
$48.6M 2.05%
241,581
-279,592
-54% -$56.7M
TERN
22
DELISTED
Terns Pharmaceuticals
TERN
$40.8M 1.72%
3,448,275
– –
CP icon
23
Canadian Pacific Kansas City
CP
$85B
$38.4M 1.62%
498,810
-267,030
-35% -$20.6M
NKE icon
24
Nike
NKE
$60.5B
$37.7M 1.59%
307,637
-190,300
-38% -$23.4M
KDNY
25
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$36.3M 1.53%
1,568,797
+123,967
+9% +$2.96M
1
2 3 4 5

Similar funds

NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
ENV
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Aaron Cowen's Q1 2023 Portfolio in Review

As of Q1 2023, Aaron Cowen held 115 positions worth $2.37B, down 0.57% from $2.38B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Aaron Cowen's Q1 2023 filing shows 26 new, 36 increased, 14 reduced and 20 closed positions. Its largest new stake was Amazon: 559,490 shares worth $57.8M. The largest sale was Otis Worldwide, an estimated $102M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 47% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Aaron Cowen's largest Q1 2023 buy was Amazon: 559,490 shares worth $57.8M.
  • Aaron Cowen added most to Elevance Health in Q1 2023, an estimated $60.1M increase.
  • Aaron Cowen's biggest Q1 2023 reduction was Union Pacific, cutting an estimated $56.7M.
  • Aaron Cowen fully exited Otis Worldwide in Q1 2023, selling an estimated $102M.
  • Aaron Cowen's ten largest holdings make up 39% of its $2.37B portfolio in Q1 2023.
  • Aaron Cowen opened 26 new positions and closed 20 in Q1 2023.
  • Aaron Cowen's portfolio value fell 0.57% quarter-over-quarter to $2.37B.

Based on Suvretta Capital Management's 13F filing for Q1 2023, filed 15 May 2023.